v3.23.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
ASSETS    
Cash $ 1,847,239 $ 4,238,006
Digital Assets (Note 2) 1,992,557 888,026
Finance receivables 14,097 26,802
Marketable securities (Note 5) 8,668 4,290
Notes receivable from Seastar Medical Holding Corporation (Note 5) 2,238,442 3,807,749
Prepaid expenses and other assets 1,425,585 1,233,322
Income tax receivable 293,466 293,466
Current assets 7,820,054 10,491,661
Fixed assets, net (Note 3) 27,208,981 27,192,317
Deposits on mining equipment (Note 4) 282,171 525,219
Hosting services deposits (Note 4) 2,357,658 2,200,452
Real estate assets owned 80,057 80,057
Long-term investments - debt security (Note 5)   2,402,542
Less: Allowance for losses on debt security (Note 5)   (1,052,542)
Long-term investments - debt security, net (Note 5)   1,350,000
Long-term investments - equity securities (Note 5) 188,493 464,778
Investment in Seastar Medical Holding Corporation (Note 5) $ 1,345,500 $ 10,608,750
Investment, Issuer Affiliation [Extensible Enumeration] us-gaap:InvestmentAffiliatedIssuerMember us-gaap:InvestmentAffiliatedIssuerMember
Symbiont intangible assets (Note 11) $ 2,804,902  
Operating lease - right of use assets (Note 8) 239,671 $ 265,658
Other assets 10,726 10,726
Long-term assets 34,518,159 42,697,957
Total assets 42,338,213 53,189,618
Liabilities and stockholders' equity    
Accounts payable and accrued expenses 2,005,147 1,570,906
Note payable - short-term (Note 6) 119,353 475,775
Due to related parties (Note 7) $ 68,217 $ 75,488
Other Liability, Current, Related and Nonrelated Party Status [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of lease liability (Note 8) $ 94,509 $ 90,823
Total current liabilities 2,287,226 2,212,992
Lease liability - net of current portion (Note 8) 151,685 179,397
Long-term liabilities 151,685 179,397
Total liabilities 2,438,911 2,392,389
Stockholders' equity (Note 9)    
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of June 30, 2023 and December 31, 2022
Common stock, par value $.001; 350,000,000 shares authorized; 14,651,883 shares issued and outstanding as of June 30, 2023 and 13,091,883 as of December 31, 2022 14,652 13,092
Additional paid-in capital 94,100,806 92,195,341
Accumulated deficit (52,952,718) (43,017,207)
Total LM Funding America stockholders' equity 41,162,740 49,191,226
Non-controlling interest (1,263,438) 1,606,003
Total stockholders’ equity 39,899,302 50,797,229
Total liabilities and stockholders’ equity $ 42,338,213 $ 53,189,618

Source

HTML PDF
ZIP